Mursla helping on COVID-19

Updated: Aug 31

Mursla is dedicating resources to help improve COVID-19 diagnostics & therapeutics solutions.


We are currently capitalising upon our expertise in exosome-based medical applications & nanobiotech technologies to help on: - Diagnostics: Develop a novel isolation and detection tool of SARS-CoV-2 virion, which is very similar in size & structure as exosome. - Therapeutics: Coordinate a consortium focused on developing stem cell-derived exosome therapy for COVID-19 hospitalized patients exhibiting life-threatening Acute Respiratory Distress Syndrome (ARDS) and/or for COVID-19 recovered patients suffering from heavily impaired lungs.


We are disseminating less-known tech & bio facts on the situation (e.g. diagnostics tools, link between exosomes & viruses) via academic publications and social media.


Lessons for SARS-CoV-2 Study (COVID-19 Disease) From Its Exosome Relatives




We hope to be as helpful as possible to our community during those difficult times.

©

2020 Mursla Ltd.

181 Cambridge Science Park, CB4 0GJ, Cambridge, U.K.

  • Twitter - White Circle
  • LinkedIn - White Circle